DK0608568T3 - Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler - Google Patents

Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler

Info

Publication number
DK0608568T3
DK0608568T3 DK93121091T DK93121091T DK0608568T3 DK 0608568 T3 DK0608568 T3 DK 0608568T3 DK 93121091 T DK93121091 T DK 93121091T DK 93121091 T DK93121091 T DK 93121091T DK 0608568 T3 DK0608568 T3 DK 0608568T3
Authority
DK
Denmark
Prior art keywords
beta
aminocycloalkanobenzodioxols
adrenergic agents
selective adrenergic
selective
Prior art date
Application number
DK93121091T
Other languages
Danish (da)
English (en)
Inventor
Joseph William Epstein
Minu Dhanjisha Dutia
Gary Harold Birnberg
Gary Edward Walker
Jonathan David Bloom
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0608568T3 publication Critical patent/DK0608568T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK93121091T 1993-01-29 1993-12-30 Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler DK0608568T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1097393A 1993-01-29 1993-01-29

Publications (1)

Publication Number Publication Date
DK0608568T3 true DK0608568T3 (da) 1998-09-28

Family

ID=21748304

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93121091T DK0608568T3 (da) 1993-01-29 1993-12-30 Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler

Country Status (10)

Country Link
US (2) US5510376A (ja)
EP (1) EP0608568B1 (ja)
JP (1) JPH072831A (ja)
KR (1) KR940018376A (ja)
AT (1) ATE163930T1 (ja)
CA (1) CA2114359A1 (ja)
DE (1) DE69317399T2 (ja)
DK (1) DK0608568T3 (ja)
ES (1) ES2115003T3 (ja)
SG (1) SG47557A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
CA2220759C (en) * 1995-05-12 2009-01-20 Nisshin Flour Milling Co. Ltd. 1,4-benzodioxin derivatives
EP0801060A1 (en) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclic Beta-3 Adrenergenic Agonists
DE69940484D1 (de) 1998-04-06 2009-04-09 Astellas Pharma Inc Verwendung von beta-3-adrenergen-Rezeptoren Agonisten in der Behandlung von Dysurie
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
DE10142722A1 (de) * 2001-08-31 2003-03-27 Aventis Pharma Deutschland GmbH, 65929 Frankfurt C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
JP5535931B2 (ja) 2008-10-27 2014-07-02 武田薬品工業株式会社 二環性化合物
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles

Also Published As

Publication number Publication date
EP0608568B1 (en) 1998-03-11
US5594027A (en) 1997-01-14
ES2115003T3 (es) 1998-06-16
ATE163930T1 (de) 1998-03-15
CA2114359A1 (en) 1994-07-30
KR940018376A (ko) 1994-08-16
DE69317399D1 (de) 1998-04-16
EP0608568A1 (en) 1994-08-03
US5510376A (en) 1996-04-23
JPH072831A (ja) 1995-01-06
SG47557A1 (en) 1998-04-17
DE69317399T2 (de) 1998-07-02

Similar Documents

Publication Publication Date Title
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
DK0608568T3 (da) Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
DK0707007T3 (da) Amino(thio)etherderivater som CNS-aktive midler
DK0486948T3 (da) Forbindelser, der hæmmer retrovirale proteaser
NO920767D0 (no) Pyranylcyanoguanidin-derivater
ATE218859T1 (de) Liganden des neuropeptids y
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
FI901956A7 (fi) Uusia naftalenyylialkyyli-3H-1,2,3,5-oksatiadiatsoli-2-oksideja, jotka ovat käyttökelpoisia antihyperglykeemisinä aineina
NO995963D0 (no) Karboksamider anvendelige som 5-HTIF-agonister
PT99503A (pt) Processo para a preparacao de novos derivados da n-benzoil-prolina e de composicoes farmaceuticas que os contem
ES2094136T3 (es) Intermediarios quirales de 1,5-diyodo-2-metoxi o benciloxi.
PT97259A (pt) Processo para a estabilizacao de isotiazolonas com fenoxialcanois
DE69121259D1 (de) Beta-Lactam-Verbindungen und ihre Herstellung
ATE250021T1 (de) Hydroxycyclopentanone
DK0566175T3 (da) 3,4-diaryl-(5H)-furan-2-on-baserede forbindelser med fungicid aktivitet
AR009452A1 (es) Compuestos de dihalopropeno, los agentes insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos.
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
ITMI930819A1 (it) Derivati eterobiciclici ad attivita' fungicida
ATE72445T1 (de) 4'-epi-4'-aminoanthracycline.
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
BR9507857A (pt) Um processo para a preparação de derivados de 5,6-Diidroxi-2-amino-1,2,3,4-tetraidronaftaleno
ITMI920228A1 (it) Tiazolilpirroli ad attivita' fungicida
ATE100996T1 (de) Blattglanzmittel.
PT89130A (pt) Processo para a preparacao de novos compostos de azol